Shortly after our previous email, the Food and Drug Administration (FDA) announced there will be a delay in the evaluation of the Pfizer-BioNTech COVID-19 vaccine for age 6 months through 4 years of age. This decision was made to allow more time to evaluate data on a third dose and if three doses will be included in the Emergency Use Authorization (EUA).
“Since the early days of the pandemic, we’ve always followed the science in this ever-changing situation,” Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research, said during a press conference. “Data has come in so rapidly and we need to be able to look through the data. It makes sense for us to wait until we have the data from the evaluation of a third dose before taking action.” – American Academy of Pediatrics News
As previously mentioned, we do have COVID vaccines still available for patients 5 years of age and older! Please contact our office to schedule your child’s doses for their vaccines or book on the patient portal today!
Thank you for trusting us with your child’s care!
Additional Resources and Information:
- Coronavirus (COVID-19) Update: Coronavirus (COVID-19) Update: FDA Postpones Advisory Committee Meeting to Discuss Request for Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age
- American Academy of Pediatrics: COVID Vaccine Fact Sheet
- American Academy of Pediatrics: Why Should my Child get the COVID Vaccine Video
Schedule your child’s next pediatric appointment today!